These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 12704585

  • 1. Other immunosuppressive agents for focal segmental glomerulosclerosis.
    Ponticelli C, Passerini P.
    Semin Nephrol; 2003 Mar; 23(2):242-8. PubMed ID: 12704585
    [Abstract] [Full Text] [Related]

  • 2. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 4. Alternative treatments for focal and segmental glomerular sclerosis.
    Ponticelli C, Passerini P.
    Clin Nephrol; 2001 May; 55(5):345-8. PubMed ID: 11393378
    [Abstract] [Full Text] [Related]

  • 5. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 May; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.
    Cattran DC, Wang MM, Appel G, Matalon A, Briggs W.
    Clin Nephrol; 2004 Dec; 62(6):405-11. PubMed ID: 15630898
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
    Gargah TT, Lakhoua MR.
    J Nephrol; 2011 Dec; 24(2):203-7. PubMed ID: 21319130
    [Abstract] [Full Text] [Related]

  • 8. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J, Radhakrishnan J.
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
    Segarra Medrano A, Vila Presas J, Pou Clavé L, Majó Masferrer J, Camps Doménech J.
    Nefrologia; 2011 Sep; 31(3):286-91. PubMed ID: 21468162
    [Abstract] [Full Text] [Related]

  • 10. Treatment of focal segmental glomerulosclerosis.
    Meyrier A.
    Expert Opin Pharmacother; 2005 Aug; 6(9):1539-49. PubMed ID: 16086641
    [Abstract] [Full Text] [Related]

  • 11. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Soliman AR, Maamoun H, Soliman H, Ahmed RM.
    Rom J Intern Med; 2021 Jun 01; 59(2):127-133. PubMed ID: 33565308
    [Abstract] [Full Text] [Related]

  • 12. Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
    Kuhn C, Kuhn A, Markau S, Kästner U, Osten B.
    J Clin Apher; 2006 Dec 01; 21(4):266-70. PubMed ID: 17120233
    [Abstract] [Full Text] [Related]

  • 13. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
    Passerini P, Scolari F, Frasca' GM, Leoni A, Venturelli C, Dallera N, Ravera S, Balestra E, Freddi P, Fanciulli E, D'Arezzo M, Sagripanti S.
    G Ital Nefrol; 2009 Dec 01; 26(5):563-76. PubMed ID: 19802802
    [Abstract] [Full Text] [Related]

  • 14. Primum non nocere: Should adults with idiopathic FSGS receive steroids?
    Franceschini N, Hogan SL, Falk RJ.
    Semin Nephrol; 2003 Mar 01; 23(2):229-33. PubMed ID: 12704583
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
    Moudgil A, Bagga A, Jordan SC.
    Pediatr Nephrol; 2005 Oct 01; 20(10):1376-81. PubMed ID: 15977023
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L, Ganguli A, Rathi M, Kohli HS, Gupta KL, Joshi K, Sakhuja V, Jha V.
    Nephrol Dial Transplant; 2008 Jun 01; 23(6):1926-30. PubMed ID: 17989103
    [Abstract] [Full Text] [Related]

  • 17. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K, El-Reshaid W, Madda J.
    Ren Fail; 2005 Jun 01; 27(5):523-30. PubMed ID: 16152989
    [Abstract] [Full Text] [Related]

  • 18. Therapy-resistant focal and segmental glomerulosclerosis.
    Kveder R.
    Nephrol Dial Transplant; 2003 Jul 01; 18 Suppl 5():v34-7. PubMed ID: 12817066
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil in the treatment of steroid-resistant primary focal segmental glomerulosclerosis.
    Tang S, Ho YW, Leung CY, Lai KN.
    J Nephrol; 2005 Jul 01; 18(4):429-32. PubMed ID: 16245248
    [Abstract] [Full Text] [Related]

  • 20. Immunosupressive therapy in children with steroid-resistant nephrotic syndrome: single center experience.
    Echeverri CV, Valencia GA, Higuita LM, Gayubo AK, Ochoa CL, Rosas LF, Muñoz LC, Sierra J, Zuleta JJ, Ruiz JJ.
    J Bras Nefrol; 2013 Jul 01; 35(3):200-5. PubMed ID: 24100739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.